A detailed history of Susquehanna Fundamental Investments, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 7,450 shares of GKOS stock, worth $1.17 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,450
Holding current value
$1.17 Million
% of portfolio
0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$89.48 - $118.35 $666,626 - $881,707
7,450 New
7,450 $882 Million
Q4 2022

Feb 14, 2023

SELL
$40.82 - $57.75 $1.03 Million - $1.46 Million
-25,319 Reduced 39.31%
39,096 $1.71 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $1.74 Million - $2.18 Million
37,202 Added 136.71%
64,415 $3.43 Million
Q1 2022

May 16, 2022

BUY
$44.33 - $57.82 $1.21 Million - $1.57 Million
27,213 New
27,213 $1.57 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.